NNovo Nordisk Read More Novo Nordisk’s Subscription Gamble Meets a Formidable New Rival2026-04-20 Novo Nordisk shares fall 50% from highs as Eli Lilly’s oral GLP-1 pill challenges Wegovy. The firm launches…
NNovo Nordisk Read More Novo Nordisk’s Oral Ambitions Face a Formidable Rival and Fiscal Headwinds2026-04-10 Novo Nordisk touts superior weight loss & tolerability for its oral Wegovy pill vs Lilly’s Foundayo, while launching…